Company
Contraline, Inc.
| Industry | clinical-stage biopharmaceutical company developing novel male contraceptives |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Contraline, Inc. | Series B | 2026-06-03 |
| Contraline, Inc. | Funding | 2022-11-10 |
Company
| Industry | clinical-stage biopharmaceutical company developing novel male contraceptives |
|---|
| Company | Round | Date |
|---|---|---|
| Contraline, Inc. | Series B | 2026-06-03 |
| Contraline, Inc. | Funding | 2022-11-10 |